Health Canada
- Status: approved
remimazolam combined with propofol and alfentanil (remimazolam combined with propofol and alfentanil) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
First Affiliated Hospital of Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.